Patent details

300909 Product Name: Ribociclib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300909
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2331547
Status:
SPC granted but not yet in force
Application number:
300909
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1221
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/08/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/11/2017
First Marketing Authorization date:
24/08/2017
Grant date:
19/12/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
10/11/2017
SPC/SPC Extension Expiration Date:
23/08/2032
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
09/11/2017
 
 

 

Name:
Astex Therapeutics Ltd.
Address:
436 Cambridge Science Park Milton Road, CAMBRIDGE CB4 0QA, United Kingdom (GB)

From:
09/11/2017
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
09/11/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
51/17
Publication date:
20/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
46/17
Publication date:
15/11/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/08/2029
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
19/12/2017 Outgoing Correspondence Decision grant 1 PDF /7/9/0/3/1/0800213097/docs/300909_6_outgoingcorrespondence20171220112800209.pdf
19/12/2017 SPC Documents Certificate SPC 1 PDF /7/9/0/3/1/0800213097/docs/300909_8_supplprotectioncertificate20171220112800420.pdf
10/11/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /7/9/0/3/1/0800213097/docs/300909_4_173735l174.pdf
09/11/2017 SPC Documents Summary of the characteristics of the product 19 PDF /7/9/0/3/1/0800213097/docs/300909_0_supplprotectioncertificate20171110015917577.pdf
09/11/2017 SPC Documents Annex SPC 2 PDF /7/9/0/3/1/0800213097/docs/300909_1_supplprotectioncertificate20171110015917634.pdf
09/11/2017 SPC Documents Marketing Authorization SPC 4 PDF /7/9/0/3/1/0800213097/docs/300909_2_supplprotectioncertificate20171110015917745.pdf
09/11/2017 SPC Documents Annex SPC 18 PDF /7/9/0/3/1/0800213097/docs/300909_3_supplprotectioncertificate20171110015917689.pdf
09/11/2017 SPC Documents Annex SPC 36 PDF /7/9/0/3/1/0800213097/docs/300909_5_supplprotectioncertificate20210114110238876.pdf
09/11/2017 Application Form First filed application form 2 PDF /7/9/0/3/1/0800213097/docs/300909_7_applicationform20171110015917453.pdf